{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T08:08:41Z","timestamp":1791446921536,"version":"4.3.3"},"reference-count":37,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2018,2,28]],"date-time":"2018-02-28T00:00:00Z","timestamp":1519776000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,5,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>Up to one-third of patients with diabetes mellitus and heart failure (HF) are treated with insulin. As insulin causes sodium retention and hypoglycaemia, its use might be associated with worse outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>We examined two datasets: 24\u2009012 patients with HF from four large randomized trials and an administrative database of 4 million individuals, 103\u2009857 of whom with HF. In the former, survival was examined using Cox proportional hazards models adjusted for baseline variables and separately for propensity scores. Fine\u2013Gray competing risk regression models were used to assess the risk of hospitalization for HF. For the latter, a case\u2013control nested within a population-based cohort study was conducted with propensity score. Prevalence of diabetes mellitus at study entry ranged from 25.5% to 29.5% across trials. Insulin alone or in combination with oral hypoglycaemic drugs was prescribed at randomization to 24.4% to 34.5% of the patients with diabetes. The rates of death from any cause and hospitalization for HF were higher in patients with vs. without diabetes, and highest of all in patients prescribed insulin [propensity score pooled hazard ratio for all-cause mortality 1.27 (1.16\u20131.38), for HF hospitalization 1.23 (1.13\u20131.33)]. In the administrative registry, insulin prescription was associated with a higher risk of all-cause death [odds ratio (OR) 2.02, 95% confidence interval (CI) 1.87\u20132.19] and rehospitalization for HF (OR 1.42, 95% CI 1.32\u20131.53).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Whether insulin use is associated with poor outcomes in HF should be investigated further with controlled trials, as should the possibility that there may be safer alternative glucose-lowering treatments for patients with HF and type 2 diabetes mellitus.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/ejhf.1146","type":"journal-article","created":{"date-parts":[[2018,2,28]],"date-time":"2018-02-28T05:43:02Z","timestamp":1519796582000},"page":"888-895","source":"Crossref","is-referenced-by-count":102,"title":["Treatment with Insulin is Associated with Worse Outcome in Patients with Chronic Heart Failure and Diabetes"],"prefix":"10.1093","volume":"20","author":[{"given":"Franco","family":"Cosmi","sequence":"first","affiliation":[{"name":"Department of Cardiology, Ospedale di Cortona , Cortona ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Shen","sequence":"additional","affiliation":[{"name":"BHF Cardiovascular Research Centre, University of Glasgow , Glasgow, Scotland ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michela","family":"Magnoli","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Research, IRCCS Istituto di Ricerche Farmacologiche Mario Negri , Milan ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William T.","family":"Abraham","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Davis Heart and Lung Research Institute, Ohio State University , Columbus, OH ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inder S.","family":"Anand","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, University of Minnesota , Minneapolis, MN ,","place":["USA"]},{"name":"Department of Cardiology, VA Medical Center , Minneapolis, MN ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John G.","family":"Cleland","sequence":"additional","affiliation":[{"name":"Robertson Centre for Biostatistics and Clinical Trials, University of Glasgow , Scotland, and Imperial College London ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay N.","family":"Cohn","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, University of Minnesota , Minneapolis, MN ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Cosmi","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Ospedale di Gubbio , Gubbio ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgia","family":"De Berardis","sequence":"additional","affiliation":[{"name":"CORESEARCH - Center for Outcomes Research and clinical Epidemiology , Pescara ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Dickstein","sequence":"additional","affiliation":[{"name":"Stavanger University Hospital, Stavanger, and the Institute of Internal Medicine, University of Bergen , Bergen ,","place":["Norway"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Grazia","family":"Franzosi","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Research, IRCCS Istituto di Ricerche Farmacologiche Mario Negri , Milan ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Gullestad","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Oslo University Hospital , Rikshospitalet, Oslo ,","place":["Norway"]},{"name":"Faculty of Medicine, University of Oslo , Oslo ,","place":["Norway"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pardeep S.","family":"Jhund","sequence":"additional","affiliation":[{"name":"BHF Cardiovascular Research Centre, University of Glasgow , Glasgow, Scotland ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Kjekshus","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Oslo University Hospital , Rikshospitalet, Oslo ,","place":["Norway"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"K\u00f8ber","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Rigshospitalet, University Hospital , Copenhagen ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vito","family":"Lepore","sequence":"additional","affiliation":[{"name":"CORESEARCH - Center for Outcomes Research and clinical Epidemiology , Pescara ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Lucisano","sequence":"additional","affiliation":[{"name":"CORESEARCH - Center for Outcomes Research and clinical Epidemiology , Pescara ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aldo P.","family":"Maggioni","sequence":"additional","affiliation":[{"name":"ANMCO Research Center , Florence ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serge","family":"Masson","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Research, IRCCS Istituto di Ricerche Farmacologiche Mario Negri , Milan ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John J.V.","family":"McMurray","sequence":"additional","affiliation":[{"name":"BHF Cardiovascular Research Centre, University of Glasgow , Glasgow, Scotland ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Nicolucci","sequence":"additional","affiliation":[{"name":"CORESEARCH - Center for Outcomes Research and clinical Epidemiology , Pescara ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vito","family":"Petrarolo","sequence":"additional","affiliation":[{"name":"Regional Health Agency of Puglia , Bari ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Robusto","sequence":"additional","affiliation":[{"name":"CORESEARCH - Center for Outcomes Research and clinical Epidemiology , Pescara ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lidia","family":"Staszewsky","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Research, IRCCS Istituto di Ricerche Farmacologiche Mario Negri , Milan ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Tavazzi","sequence":"additional","affiliation":[{"name":"GVM Hospitals of Care and Research, E.S. Health Science Foundation , Cotignola ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Teli","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Research, IRCCS Istituto di Ricerche Farmacologiche Mario Negri , Milan ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianni","family":"Tognoni","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Research, IRCCS Istituto di Ricerche Farmacologiche Mario Negri , Milan ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Wikstrand","sequence":"additional","affiliation":[{"name":"Sahlgrenska Academy, Gothenburg University \u00a0","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Latini","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Research, IRCCS Istituto di Ricerche Farmacologiche Mario Negri , Milan ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,2,28]]},"reference":[{"key":"2026011721234673200_ejhf1146-bib-0001","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0002-9149(74)90089-7","article-title":"Role of diabetes in congestive heart failure: the Framingham study","volume":"34","author":"Kannel","year":"1974","journal-title":"Am J Cardiol"},{"key":"2026011721234673200_ejhf1146-bib-0002","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.2337\/diacare.24.9.1614","article-title":"Congestive heart failure in type 2 diabetes: prevalence, incidence, and risk factors","volume":"24","author":"Nichols","year":"2001","journal-title":"Diabetes Care"},{"key":"2026011721234673200_ejhf1146-bib-0003","doi-asserted-by":"crossref","first-page":"61","DOI":"10.2337\/diacare.26.1.61","article-title":"Age- and sex-specific prevalences of diabetes and impaired glucose regulation in 13 European cohorts","volume":"26","author":"DECODE Study Group","year":"2003","journal-title":"Diabetes Care"},{"key":"2026011721234673200_ejhf1146-bib-0004","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1161\/CIRCULATIONAHA.106.661405","article-title":"Glucose levels predict hospitalization for congestive heart failure in patients at high cardiovascular risk","volume":"115","author":"Held","year":"2007","journal-title":"Circulation"},{"key":"2026011721234673200_ejhf1146-bib-0005","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.115.002560","article-title":"Risk related to pre-diabetes mellitus and diabetes mellitus in heart failure with reduced ejection fraction: insights from Prospective Comparison of ARNI With ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure trial","volume":"9","author":"Kristensen","year":"2016","journal-title":"Circ Heart Fail"},{"key":"2026011721234673200_ejhf1146-bib-0006","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1161\/CIRCULATIONAHA.116.024593","article-title":"Clinical and echocardiographic characteristics and cardiovascular outcomes according to diabetes status in patients with heart failure and preserved ejection fraction. A report from the Irbesartan in Heart Failure with Preserved Ejection Fraction Trial (I-Preserve)","volume":"135","author":"Kristensen","year":"2017","journal-title":"Circulation"},{"key":"2026011721234673200_ejhf1146-bib-0007","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1093\/eurheartj\/ehn156","article-title":"Diabetes, left ventricular systolic dysfunction, and chronic heart failure","volume":"29","author":"MacDonald","year":"2008","journal-title":"Eur Heart J"},{"key":"2026011721234673200_ejhf1146-bib-0008","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1093\/eurheartj\/ehn153","article-title":"Impact of diabetes on outcomes in patients with low and preserved ejection fraction heart failure: an analysis of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme","volume":"29","author":"MacDonald","year":"2008","journal-title":"Eur Heart J"},{"key":"2026011721234673200_ejhf1146-bib-0009","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1016\/S0140-6736(14)61402-1","article-title":"Heart failure in diabetes: effects of anti-hyperglycaemic drug therapy","volume":"385","author":"Gilbert","year":"2015","journal-title":"Lancet"},{"key":"2026011721234673200_ejhf1146-bib-0010","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S2213-8587(14)70031-2","article-title":"Heart failure: a cardiovascular outcome in diabetes that can no longer be ignored","volume":"2","author":"McMurray","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2026011721234673200_ejhf1146-bib-0011","doi-asserted-by":"crossref","first-page":"e535","DOI":"10.1161\/CIR.0000000000000450","article-title":"American Heart Association Heart Failure and Transplantation Committee of the Council on Clinical Cardiology; Council on Cardiovascular Surgery and Anesthesia; Council on Cardiovascular and Stroke Nursing; Council on Hypertension; and Council on Quality and Outcomes Research. Contributory risk and management of comorbidities of hypertension, obesity, diabetes mellitus, hyperlipidemia, and metabolic syndrome in chronic heart failure: a scientific statement from the American Heart Association","volume":"134","author":"Bozkurt","year":"2016","journal-title":"Circulation"},{"key":"2026011721234673200_ejhf1146-bib-0012","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1172\/JCI107996","article-title":"The effect of insulin on renal handling of sodium, potassium, calcium, and phosphate in man","volume":"55","author":"DeFronzo","year":"1975","journal-title":"J Clin Invest"},{"key":"2026011721234673200_ejhf1146-bib-0013","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1007\/BF00274259","article-title":"Effects of insulin on kidney function and sodium excretion in healthy subjects","volume":"32","author":"Sk\u00f8tt","year":"1989","journal-title":"Diabetologia"},{"key":"2026011721234673200_ejhf1146-bib-0014","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1016\/0002-9149(89)90025-8","article-title":"Hypoglycaemia-induced silent myocardial ischemia","volume":"63","author":"Pladziewicz","year":"1989","journal-title":"Am J Cardiol"},{"issue":"Suppl 2","key":"2026011721234673200_ejhf1146-bib-0015","doi-asserted-by":"crossref","first-page":"S205","DOI":"10.2337\/dcS15-3014","article-title":"Hypoglycaemia and cardiovascular risk: is there a major link?","volume":"39","author":"Hanefeld","year":"2016","journal-title":"Diabetes Care"},{"key":"2026011721234673200_ejhf1146-bib-0016","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1136\/bmj.39314.620174.80","article-title":"Benefits and harms of antidiabetic agents in patients with diabetes and heart failure: systematic review","volume":"335","author":"Eurich","year":"2007","journal-title":"BMJ"},{"key":"2026011721234673200_ejhf1146-bib-0017","article-title":"Diabetes treatments and risk of heart failure, cardiovascular disease, and all cause mortality: cohort study in primary care","volume":"354","author":"Hippisley-Cox","year":"2016","journal-title":"BMJ"},{"key":"2026011721234673200_ejhf1146-bib-0018","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1056\/NEJMoa010713","article-title":"A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure","volume":"345","author":"Cohn","year":"2001","journal-title":"N Engl J Med"},{"key":"2026011721234673200_ejhf1146-bib-0019","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1056\/NEJMoa0706201","article-title":"Rosuvastatin in older patients with systolic heart failure","volume":"357","author":"Kjekshus","year":"2007","journal-title":"N Engl J Med"},{"key":"2026011721234673200_ejhf1146-bib-0020","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/S0140-6736(08)61239-8","article-title":"Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial","volume":"372","author":"GISSI-HF Investigators","year":"2008","journal-title":"Lancet"},{"key":"2026011721234673200_ejhf1146-bib-0021","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1056\/NEJMoa1514859","article-title":"Aliskiren, enalapril, or aliskiren and enalapril in heart failure","volume":"374","author":"JJ","year":"2016","journal-title":"N Engl J Med"},{"key":"2026011721234673200_ejhf1146-bib-0022","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0149203","article-title":"The Drug Derived Complexity Index (DDCI) predicts mortality, unplanned hospitalization and hospital readmissions at the population level","volume":"11","author":"Robusto","year":"2016","journal-title":"PLoS One"},{"key":"2026011721234673200_ejhf1146-bib-0023","first-page":"509","article-title":"Insulin therapy may hasten congestive heart failure in cardiac patients: case series and review of the literature","volume":"9","author":"Cosmi","year":"2008","journal-title":"G Ital Cardiol"},{"key":"2026011721234673200_ejhf1146-bib-0024","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1161\/CIRCHEARTFAILURE.108.821785","article-title":"Loop diuretics in acute decompensated heart failure: necessary? Evil? A necessary evil?","volume":"2","author":"Felker","year":"2009","journal-title":"Circ Heart Fail"},{"key":"2026011721234673200_ejhf1146-bib-0025","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1001\/jama.2016.9400","article-title":"Comparison of clinical outcomes and adverse events associated with glucose-lowering drugs in patients with type 2 diabetes: a meta-analysis","volume":"316","author":"Palmer","year":"2016","journal-title":"JAMA"},{"key":"2026011721234673200_ejhf1146-bib-0026","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ahj.2005.10.008","article-title":"An unexpected inverse relationship between HbA1c levels and mortality in patients with diabetes and advanced systolic heart failure","volume":"151","author":"Eshaghian","year":"2006","journal-title":"Am Heart J"},{"key":"2026011721234673200_ejhf1146-bib-0027","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1161\/CIRCULATIONAHA.116.022281","article-title":"Inhibiting insulin-mediated \u03b22-adrenergic receptor activation prevents diabetes-associated cardiac dysfunction","volume":"135","author":"Wang","year":"2017","journal-title":"Circulation"},{"key":"2026011721234673200_ejhf1146-bib-0028","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1056\/NEJMoa1203858","article-title":"Basal insulin and cardiovascular and other outcomes in dysglycemia","volume":"367","author":"Gerstein","year":"2012","journal-title":"N Engl J Med"},{"key":"2026011721234673200_ejhf1146-bib-0029","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1093\/eurheartj\/ehv728","article-title":"Heart failure outcomes with empagliflozin in patients with type 2 diabetes at high cardiovascular risk: results of the EMPA-REG OUTCOME\u00ae trial","volume":"37","author":"Fitchett","year":"2016","journal-title":"Eur Heart J"},{"key":"2026011721234673200_ejhf1146-bib-0030","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","article-title":"Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes","volume":"373","author":"Zinman","year":"2015","journal-title":"N Engl J Med"},{"key":"2026011721234673200_ejhf1146-bib-0031","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1603827","article-title":"Liraglutide and cardiovascular outcomes in type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N Engl J Med"},{"key":"2026011721234673200_ejhf1146-bib-0032","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1056\/NEJMoa1607141","article-title":"Semaglutide and cardiovascular outcomes in patients with type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N Engl J Med"},{"key":"2026011721234673200_ejhf1146-bib-0033","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/ejhf.657","article-title":"Effect of liraglutide, a glucagon-like peptide-1 analogue, on left ventricular function in stable chronic heart failure patients with and without diabetes (LIVE)\u2014a multicentre, double-blind, randomised, placebo-controlled trial","volume":"19","author":"Jorsal","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"2026011721234673200_ejhf1146-bib-0034","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/ejhf.633","article-title":"Heart failure outcomes in clinical trials of glucose-lowering agents in patients with diabetes","volume":"19","author":"Fitchett","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"2026011721234673200_ejhf1146-bib-0035","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1001\/jama.2013.278040","article-title":"Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women's Health Initiative randomized trials","volume":"310","author":"Manson","year":"2013","journal-title":"JAMA"},{"key":"2026011721234673200_ejhf1146-bib-0036","article-title":"Safety and efficacy of digoxin: systematic review and meta-analysis of observational and controlled trial data","volume":"351","author":"Ziff","year":"2015","journal-title":"BMJ"},{"key":"2026011721234673200_ejhf1146-bib-0037","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1002\/ejhf.455","article-title":"Mean HbA1c and mortality in diabetic individuals with heart failure: a population cohort study","volume":"18","author":"Elder","year":"2016","journal-title":"Eur J Heart Fail"}],"container-title":["European Journal of Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fejhf.1146","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/eurjhf\/article-pdf\/20\/5\/888\/66269283\/eurjhf_20_5_888.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurjhf\/article-pdf\/20\/5\/888\/66269283\/eurjhf_20_5_888.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T02:26:13Z","timestamp":1768703173000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurjhf\/article\/20\/5\/888\/8414715"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,28]]},"references-count":37,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2018,2,28]]},"published-print":{"date-parts":[[2018,5,1]]}},"URL":"https:\/\/doi.org\/10.1002\/ejhf.1146","relation":{},"ISSN":["1388-9842","1879-0844"],"issn-type":[{"value":"1388-9842","type":"print"},{"value":"1879-0844","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,5]]},"published":{"date-parts":[[2018,2,28]]}}}